Kyntra Bio KYNB
NASDAQ KYNB
$3.35 -0.14 (-4.15%)
As of: Nov 16, 2026 · 10:25 AM EST

Kyntra Bio (KYNB) Divestments (2025)

Updated

Kyntra Bio (KYNB) posted Divestments of $6.41 million for Q4 2025.

Analysis

Kyntra Bio (KYNB) Divestments (2025) Analysis & Trends

For FY2025, Kyntra Bio's Divestments came in at $96.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,304.33 Bn 1,277.95 Bn 20.46 Bn -
2 Johnson & Johnson 692.09 Bn 611.95 Bn 17.30 Bn -
3 AbbVie 527.57 Bn 495.58 Bn 13.12 Bn -
4 Merck 366.55 Bn 329.49 Bn 13.19 Bn -
5 Novartis Ag 315.36 Bn 288.60 Bn - 42.00 Mn
6 Astrazeneca 289.39 Bn 262.91 Bn 13.26 Bn -
7 Amgen 255.08 Bn 206.73 Bn 7.58 Bn -
8 Gilead Sciences 212.20 Bn 187.31 Bn 6.73 Bn -
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn -
10 Kyntra Bio 13.08 Mn -394.87 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.41 Mn
API Access

Kyntra Bio Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=KYNB&period=max&api_key=YOUR_API_KEY